Clin2
NCT06610422Possibly a fitNot yet recruiting

Nerve damage and antibodies in lupus patients

Lupus Nephritis

Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.

This study looks at whether certain antibodies in the blood are linked to nerve damage (neuropathy) in women with lupus, especially those with lupus-related kidney disease. It may help understand how to better monitor or treat nerve problems in lupus.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
159 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are a woman aged 18 or older.
  • You have been diagnosed with lupus (SLE) and also have lupus affecting your kidneys (lupus nephritis).
  • You have certain antibodies in your blood (antiphospholipid antibodies or ANCA).
  • You do NOT have past or current hepatitis B or C.
  • You do NOT have a history of cancer (except a common skin cancer called basal cell carcinoma).
  • You are not on dialysis or have very advanced kidney disease (stage 5).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07505576Not yet recruiting
Antibodies and lupus kidney disease activity study

This study looks at whether a specific antibody (anti-alpha-actinin) in the blood is linked to active lupus kidney disease. It may help doctors better understand and monitor kidney problems in people with lupus.

NCT05443516Recruiting
Blood and urine markers in active lupus kidney disease

This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.

Brussels
NCT06167174Recruiting
Looking for markers to predict lupus kidney treatment response

This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.

Beijing
NCT07780045Not yet recruiting
New blood markers for lupus kidney disease

This study looks at two simple blood tests to see if they can help doctors understand and predict how lupus-related kidney disease (lupus nephritis) is progressing. The goal is to improve monitoring and treatment decisions for people with this condition.

NCT07666711Recruiting
Kidney biomarker study for lupus patients

This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.

Oslo, Oslo
NCT06631404Recruiting
Ultrasound test for lupus kidney activity

This trial uses an ultrasound to measure kidney blood flow in people with lupus kidney disease. The goal is to see if this simple test can tell how active the disease is, which might help doctors adjust treatment without needing frequent biopsies.

Sohag

Hear when a new Lupus Nephritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.